Evidence map›Paper›PMID 40104999›Full record

ReviewHuman vaccines & immunotherapeutics2025

Joint consensus on reducing the burden of invasive meningococcal disease in the Asia-Pacific region.

Gang Liu, Maria Liza Antoinette M Gonzales, Wai Hung Chan, Iqbal Ahmad Memon, Anggraini Alam, Hyunju Lee, Hetti Wickramasinghe, Quang Thai Pham, Rajeshwar Dayal, Michael Levin and 4 more

Abstract readReviewConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Review in Human vaccines & immunotherapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Gang LiuDepartment of Infectious Diseases, Beijing Children's Hospital, National Center for Children's Health, Capital Medical University, National Center for Children's Health, Beijing, China.
Maria Liza Antoinette M GonzalesDepartment of Pediatrics, Division of Infectious & Tropical Diseases, Philippine General Hospital-University of the Philippines, Manila, Philippines.
Wai Hung ChanDepartment of Paediatrics, Queen Elizabeth Hospital, Hong Kong, China.
Iqbal Ahmad MemonDepartment of Paediatrics, Sir Syed College of Medical Sciences for Girls, Karachi, Pakistan.
Anggraini AlamDepartment of Child Health, Faculty of Medicine, Universitas Padjadjaran-Hasan Sadikin General Hospital, Bandung, Indonesia.
Hyunju LeeDepartment of Pediatrics, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
Hetti WickramasingheSenior Consultant Pediatrician, Neville Fernando Teaching Hospital, Malabe, Sri Lanka.
Quang Thai PhamCommunicable Diseases Control and Prevention Department, National Institute of Hygiene and Epidemiology, Hanoi, Vietnam.
Rajeshwar DayalDepartment of Paediatrics, S.N. Medical College, Agra, India.
Michael LevinSection of Paediatric Infectious Disease, Faculty of Medicine, Imperial College London, London, UK.
Yhu-Chering HuangDepartment of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Jim ButteryDepartment of Infectious Disease, The Royal Children's Hospital Melbourne, Parkville, Australia.
Anna Lisa T Ong-LimDepartment of Pediatrics, Division of Infectious & Tropical Diseases, Philippine General Hospital-University of the Philippines, Manila, Philippines.
Mike Yat Wah KwanDepartment of Paediatrics and Adolescent Medicine, Princess Margaret Hospital, Hong Kong, China.ORCID 0000-0002-1476-9625

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Invasive meningococcal disease (IMD) imposes a heavy burden of mortality and life-long sequelae on infected individuals and has devastating impacts on their family members. International data show that meningococcal vaccination programs have reduced IMD incidence and changed the serogroup distribution of the disease. Furthermore, newer data show that although the public health measures in response to the coronavirus disease 2019 (COVID-19) pandemic temporarily reduced the incidence of IMD, there has been a resurgence in the years since. In the Asia-Pacific (APAC) region, many countries do not include meningococcal vaccines in their routine vaccination programs, and approaches to IMD surveillance are inconsistent. This review summarizes recent data and consensus statements from a group of experts from selected APAC countries on the burden of IMD in the region, evidence for vaccination, and how barriers to IMD vaccination may be addressed.

Indexed as

COVID-19Meningococcal InfectionsMeningococcal VaccinesAsiaCost of IllnessHumansImmunization ProgramsIncidenceNeisseria meningitidisVaccinationMeningococcal Vaccinesadolescent vaccinationepidemiologyInvasive meningococcal diseaseNeisseria meningitidispediatricvaccination strategiesvaccine equityvaccine hesitancy

Identifiers

PMID40104999
PMCPMC12934145

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.